English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-over-year; Positions fro Longer-term Growth and Profitability
2023-02-21
OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended December 31, 2022.
After emergency approval of more than 440 COVID-19 products, FDA decided to bind EUA!
2023-02-20
After issuing emergency use authorizations for more than 400 COVID-19 tests, the U.S. Food and Drug Administration said Wednesday that it is ending its EUA review of new in vitro diagnostics.
EDX Medical Group to Acquire Torax Biosciences
2023-02-20
UK digital diagnostics firm EDX Medical Group said Friday that it is acquiring in vitro diagnostics and immunochemistry firm Torax Biosciences.
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
2023-02-20
Labcorp, a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2022, full-year 2023 guidance.
Zybio was selected as one of the top 100 private enterprises in Chongqing in terms of science and technology innovation index
2023-02-17
Recently, Chongqing Federation of Industry and Commerce released the "Top 100 list of Chongqing Private Enterprises' Science and Technology Innovation Index", and Zybio ranked 3rd on the list.
UPDATE: FDA Winding Down COVID, Mpox Test Emergency Use Authorizations
2023-02-17
After issuing Emergency Use Authorizations for more than 400 COVID-19 tests and seven Mpox tests, the US Food and Drug Administration said Wednesday that it is nearing the end of EUA reviews of new in vitro diagnostics.
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
2023-02-17
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2022.
Danaher, Johnson & Johnson and Pfizer were listed as World's Most Admired Companies
2023-02-16
The biggest tech companies may be facing relatively tough times, but the 25th edition of the Fortune World’s Most Admired Companies All-Stars list suggests that the giants’ peers respect them as much as ever.
FDA grants EUA for Cepheid’s Xpert Mpox test
2023-02-16
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Xpert Mpox test from molecular diagnostics company Cepheid.
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
2023-02-16
QuidelOrtho Corporation, a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced financial results for the fourth quarter ended January 1, 2023.
Another Victory! RocGene’s Archimed Mini 16 Obtains Class III Medical Device Registration Certificate
2023-02-15
On February 7 2023, RocGene's independently developed Archimed Mini 16 Medical Fluorescence Quantitative PCR Instrument obtained the Class III Medical Device Registration Certificate by the National Medical Products Administration.
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
2023-02-15
QIAGEN N.V. today announced the certification of QuantiFERON-TB Gold Plus (QFT-Plus) – the world’s leading tuberculosis (TB) blood test – under the European Union’s 2017/746 In Vitro Diagnostic Medical Devices Regulation (IVDR) which is replacing the 98/79/EC In Vitro Diagnostic Directive (IVDD).
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
2023-02-15
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 1, 2023.
Former head of Abbott China R&D Center joins Sansure Biotech
2023-02-14
On February 9, Sansure Bio released an announcement on the appointment of senior management personnel.
Abbott to Acquire Cardiovascular Systems, Inc.
2023-02-14
Abbott and Cardiovascular Systems, Inc. announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
Total:
3701
Pages:
247
First
Prev
1
..
112
113
114
115
116
117
118
..
247
Next
End